Results 31 to 40 of about 8,359,193 (315)
European Journal of Heart Failure, 2021 To study loop diuretic response and effect of loop diuretic omission in ambulatory heart failure (HF) patients on chronic low‐dose loop diuretics.
Jeroen Dauw +9 more
semanticscholar +1 more source
CAPA neuropeptides and their receptor form an anti-diuretic hormone signalling system in the human disease vector, Aedes aegypti [PDF]
, 2020 Insect CAPA neuropeptides are homologs of mammalian neuromedin U and are known to influence ion and water balance by regulating the activity of the Malpighian ‘renal’ tubules (MTs).
Ber, Lindsay Taylor +7 more
core +1 more source
Mechanisms of Diuretic Resistance Study: design and rationale
ESC Heart Failure, 2020 Introduction Diuretic resistance is a common complication impairing decongestion during hospitalization for acute decompensated heart failure (ADHF). The current understanding of diuretic resistance mechanisms in ADHF is based upon extrapolations from ...
Zachary L. Cox +10 more
doaj +1 more source
Rationale and study design of intravenous loop diuretic administration in acute heart failure. DIUR-AHF [PDF]
, 2017 Aims: Although loop diuretics are the most commonly used drugs in acute heart failure (AHF) treatment, their short-term and long-term effects are relatively unknown.
Di Somma, Salvatore +5 more
core +1 more source
secCl is a cys-loop ion channel necessary for the chloride conductance that mediates hormone-induced fluid secretion in Drosophila [PDF]
, 2019 Organisms use circulating diuretic hormones to control water balance (osmolarity), thereby avoiding dehydration and managing excretion of waste products.
Dent, J. +6 more
core +2 more sources
Spanish Journal of Medicine, 2023 Introduction: Renal dysfunction and heart failure (HF) are closely intermingled, even though their pathophysiology is not fully understood. Recently, abdominal congestion, through an increase of intra-abdominal pressure (IAP), has been proposed as a ...
Silvia Crespo-Aznárez +8 more
doaj +1 more source
Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis [PDF]
, 2017 The effect of a sodium glucose cotransporter 2 inhibitor (SGLT2i) in reducing heart failure hospitalization in the EMPA-REG OUTCOMES trial has raised the possibility of using these agents to treat established heart failure.
De Vecchis +22 more
core +1 more source
International Journal of General Medicine, 2021 Shuyu Li,1,2 Qingzhen Zhao,1 Yuzhi Zhen,1 Lizhuo Li,1 Yiqing Mi,1 Tongxin Li,1 Kunshen Liu,1 Chao Liu1 1The First Cardiology Division, First Affiliated Hospital of Hebei Medical University, Shijiazhuang, 050022, People’s Republic of China; 2The Second ...
Li S +7 more
doaj
Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
Scientific Reports, 2022 Although intravenous diuretics is a cornerstone of acute heart failure treatment (AHF), its optimal initial dose is unclear. This is a post-hoc analysis of the REALITY-AHF, a prospective multicentre observational registry of AHF.
Kenji Yoshioka +15 more
doaj +1 more source